Research programme: infectious disease vaccines - PaxVax

Drug Profile

Research programme: infectious disease vaccines - PaxVax

Alternative Names: Dengue vaccine - PaxVax; Human papillomavirus infections vaccine - PaxVax; Influenza virus infections vaccine - PaxVax; Malaria vaccine - PaxVax; Poliomyelitis vaccine - PaxVax; Rabies vaccine - PaxVax; Shigella vaccine - PaxVax; Tuberculosis vaccine -PaxVax; Zika virus vaccine - PaxVax

Latest Information Update: 15 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PaxVax
  • Class Bacterial vaccines; DNA vaccines; Parasitic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Dengue; Rabies; Zika virus infection
  • No development reported Human papillomavirus infections; Influenza virus infections; Malaria; Poliomyelitis; Shigella infections; Tuberculosis

Most Recent Events

  • 13 Sep 2016 PaxVax in-licenses SPS® formulation technology platform from LEUKOCARE
  • 16 Jul 2016 No recent reports of development identified for research development in Human-papillomavirus-infections(Prevention) in USA (PO)
  • 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections(Prevention) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top